Richard Lee

Richard Lee is a clinical researcher working at the intersection of psychopharmacology, affective neuroscience and clinical psychiatry, with a focus on the behavioural and neurophysiological effects of low doses of classical psychedelics and empathogens. His recent work has examined acute subjective and behavioural responses to microdoses of lysergic acid diethylamide (LSD) in healthy volunteers, low‑dose LSD effects on event‑related potentials to emotional faces, and variability in subjective response to low doses in participants with depressed mood. He has also contributed to comparative studies of social connectedness under MDMA and methamphetamine and to pharmacological characterisation of Banisteriopsis caapi extracts and constituents with relevance to parkinsonism and monoamine oxidase inhibition.

Lee's contributions combine tightly controlled human experimental designs with neurophysiological measurements and psychometric assessment, helping to delineate dose‑dependent effects of psychedelics on emotion processing, interpersonal connectedness and subjective experience. His work informs both mechanistic models of how low and sub‑perceptual doses modulate cognition and affect, and translational questions about therapeutic potential and safety considerations of microdosing and plant‑derived monoamine oxidase inhibitors in clinical populations.